Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEED: Dorzagliatin Monotherapy in T2DM
NCT03173391Phase 3Completed
- Sponsor
- Hua Medicine
- Start
- Jul 2017
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dorzagliatin in type 2 diabetes mellitus (T2DM), sponsored by Hua Medicine. Started Jul 2017; status: completed.
02
Drugs
dorzagliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03173391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03173391.